Methotrexate - Inadequate Response Device Sub-Study

Clinical trial NCT01173120 · COMPLETED

Trial details

NCT number: NCT01173120
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)

Start date: 2009-11-01
Primary completion: 2010-02-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.